Enveric Biosciences, Inc.
ENVB
$5.32
$0.224.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.19M | -1.87M | -2.52M | -2.19M | -3.15M |
| Total Depreciation and Amortization | 39.50K | 40.40K | 40.00K | 81.00K | 82.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 269.70K | 58.30K | 206.30K | 191.30K | 883.30K |
| Change in Net Operating Assets | 100.10K | -300.00K | 382.80K | -478.90K | 877.30K |
| Cash from Operations | -1.78M | -2.08M | -1.89M | -2.39M | -1.31M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.69M | 2.99M | 449.10K | 4.45M | 483.80K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -20.40K |
| Cash from Financing | 2.69M | 2.99M | 449.10K | 4.45M | 463.40K |
| Foreign Exchange rate Adjustments | 15.60K | -9.60K | -3.60K | -3.90K | -22.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 919.90K | 907.80K | -1.44M | 2.05M | -870.70K |